Calculator topics: Difference between revisions
Jump to navigation
Jump to search
Line 13: | Line 13: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |ACTION ICU Score for Intensive Care in NSTEMI | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts risk of NSTEMI complications requiring ICU care | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |ADAPT Protocol for Cardiac Event Risk | ||
| align="left" style="background:#F5F5F5;" + |Assesses chest pain patients at 2 hours for risk of cardiac event | |||
| align="left" style="background:#F5F5F5;" + | | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |DVT | ! align="center" style="background:#DCDCDC;" + |DVT | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |AMUSE score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Evaluates the need to proceed with ultrasonography among patients with suspected DVT | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Anticoagulation | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |ATRIA Bleeding Risk Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Determines bleeding risk for patients on warfarin | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Arrythmia | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |ATRIA Stroke Risk Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Determines stroke risk in patients with atrial fibrillation | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Atrial Fibrillation Five Year Risk of Stroke (Framingham Heart Study) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke in patients with atrial fibrillation | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Atrial Fibrillation Five Year Risk of Stroke or Death (Framingham Heart Study) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke or death in patients with atrial fibrillation | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Alcoholism | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |CAGE Questions for Alcohol Use | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Screens for excessive drinking and alcoholism | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Syncope | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Canadian Syncope Risk Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 30-day serious adverse events in patients presenting with syncope | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |VTE | ! align="center" style="background:#DCDCDC;" + |VTE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Caprini score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Stratifies risk of VTE in surgical patients | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for AAA Surgery (Lee) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Calculates the approximate risk of cardiac complication after AAA surgery | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for Abdominal Surgery (Lee) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Calculates the approximate risk of cardiac complication after abdominal surgery | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for Pre-Operative Risk, revised | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates risk of cardiac complications after noncardiac surgery | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |MACE | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Cardiovascular Risk Assessment (10-year, PROCAM Score, Munster Heart Study) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 10-year cardiovascular risk based on risk factors like history of MI, diabetes or high cholesterol | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Cardiac arrest | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |CART (Cardiac Arrest Risk Triage) Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts risk of in-hospital cardiac arrest | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Calculates stroke risk for patients with atrial fibrillation, possibly better than the CHADS₂ Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |CHADS₂ Score for Atrial Fibrillation Stroke Risk | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates stroke risk in patients with atrial fibrillation | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Survival | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Charlson Comorbidity Index (CCI) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 10-year survival in patients with multiple comorbidities | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Stroke | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Cincinnati Prehospital Stroke Severity Scale (CP-SSS) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts large vessel occlusion (LVO) and severe stroke in patients with stroke symptoms | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease/Bleeding | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |CRUSADE Score for Post-MI Bleeding Risk | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Stratifies bleeding risk after NSTEMI | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |VTE | ! align="center" style="background:#DCDCDC;" + |VTE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |DASH Prediction Score for Recurrent VTE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts likelihood of recurrence of first VTE | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Dual Antiplatelet Therapy (DAPT) Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts which patients will benefit from prolonged DAPT after coronary stent placement | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Syncope | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts likelihood that syncope is from cardiac cause | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |VTE | ! align="center" style="background:#DCDCDC;" + |VTE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts need for VTE prophylaxis in admitted patients | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Geneva score for PE, original | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Determines the pre-test probability of PE based on a patient's risk factors and clinical findings | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Geneva score for PE, revised | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Objectifies risk of PE, like Wells’ score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Geneva score for PE, simplified | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Determines the pre-test probability of PE based on a patient's risk factors and clinical findings | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Cardiac arrest/Survival | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |GO-FAR (Good Outcome Following Attempted Resuscitation) Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts survival to discharge with good outcome after in-hospital cardiac arrest | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Grace Risk Score for All-Cause Mortality From Discharge to 6 Months | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Assesses the risk of 6-month mortality among patients with acute coronary syndrome | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Grace Risk Score for In-Hospital Mortality | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Assesses the risk of in-hospital mortality among patients with acute coronary syndrome | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |DVT | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |HAMILTON score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Assesses the pretest probability of DVT among ambulatory outpatients | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Bleeding | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |HAS-BLED Score for Major Bleeding Risk | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |HEART Pathway for Early Discharge in Acute Chest Pain | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Identifies emergency department patients with acute chest pain for early discharge | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |HEART Score for Major Cardiac Events | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 6-week risk of major adverse cardiac event | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Arrythmia/Bleeding | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |HEMORR₂HAGES Score for Major Bleeding Risk | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Quantifies risk of hemorrhage in elderly patients with AFib | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Hestia Criteria for Outpatient Pulmonary Embolism Treatment | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Identifies low-risk PE patients safe for outpatient treatment | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Bleeding | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |IMPROVE bleeding risk score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |VTE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |IMPROVE VTE risk score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |VTE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |IMPROVEDD VTE risk score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the probability of venous thromboembolism from the time of hospital admission up to 77 days | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Infective endocarditis/Mortality | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Infective Endocarditis (IE) Mortality Risk Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts mortality at 6 months in patients with infective endocarditis | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Marburg Heart Score (MHS) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Rules out coronary artery disease in primary care patients with chest pain | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Nephropathy | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Mehran Score for Post-PCI Contrast Nephropathy | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Syncope/Mortality | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |OESIL Score for Syncope | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates 12-month all-cause mortality in patients presenting with syncope | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Heart failure | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Ottawa Heart Failure Risk Scale (OHFRS) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Identifies ED patients with heart failure at high risk for serious adverse events | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |VTE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Padua Prediction Score for Risk of VTE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Determines anticoagulation need in hospitalized patients by risk of VTE | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |PESI (Pulmonary Embolism Severity Index) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |PESI (Pulmonary Embolism Severity Index), simplified | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 30-day outcome of patients with PE, with fewer criteria than the original PESI | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE/Bleeding | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Determine the risk of major bleeding during anticoagulant therapy | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Stroke/Mortality | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |SOAR Score for Stroke, modified | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts short-term mortality in acute ischemic stroke | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |TIMI Risk Score for STEMI | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates mortality in patients with STEMI | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |TIMI Risk Score for UA/NSTEMI | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates mortality for patients with unstable angina and non-ST elevation MI | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |DVT | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Wells score for DVT, modified | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |DVT | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Wells score for DVT, original | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Calculates Wells' Score for risk of DVT | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Wells score for Pulmonary Embolism | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Objectifies risk of pulmonary embolism | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Wells score for pulmonary embolism, modified | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Wells score for pulmonary embolism, simplified | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Anesthesia | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Cardiac Anesthesia Risk Evaluation Score (CARE) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts mortality and morbidity after cardiac surgery | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + | | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Duke Activity Status Index (DASI) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates functional capacity | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Ehlers-Danlos Syndrome | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Ehlers-Danlos Syndrome IV (vascular type) Diagnostic Criteria | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Diagnoses Ehlers-Danlos Syndrome IV (vascular type) | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Emergency Department Assessment of Chest Pain Score (EDACS) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Identifies chest pain patients with low risk of major adverse cardiac event | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |EuroSCORE for Cardiac Surgery Risk Assessment | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the mortality among cardiac surgical adult patients | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Framingham 10 Year Coronary Risk Prediction by LDL (1998 paper) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 10-year risk of coronary heart disease | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Framingham 10 Year Coronary Risk Prediction by Total Cholesterol (1998 paper) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 10-year risk of coronary heart disease | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |MACE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Framingham 10 Year Risk of General Cardiovascular Disease (2008 paper) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 10-year risk of heart disease | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Heart failure | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Framingham Heart Failure Diagnostic Criteria | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Diagnoses heart failure based on major and minor criteria | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Heart failure | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |GWTG-Heart Failure Risk Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts in-hospital all-cause heart failure mortality | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Takayasu arteritis | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Indian Takayasu Clinical Activity Score (ITAS2010) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Differentiates between active and inactive disease in Takayasu arteritis (TA) | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Bleeding | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Intracranial Bleeding Risk from Thrombolytic Therapy of MI | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the risk of intracranial hemorrhage associated with thrombolytic therapy among MI patients | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Acute Rheumatic Fever | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Jones Criteria for Acute Rheumatic Fever Diagnosis | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Diagnoses acute rheumatic fever based on major and minor criteria | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Kawasaki Disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Kawasaki Disease Diagnostic Criteria | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Diagnoses Kawasaki Disease | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Heart failure | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Killip Classification for Heart Failure | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Quantifies severity of heart failure in ACS and predicts 30-day mortality | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Readmission/Mortality | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |LACE Index for Readmission | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts 30-day readmission or death in patients on medicine and surgery wards | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Heart failure/Mortality | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |MAGGIC Risk for Heart Failure | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates 1- and 3- year mortality in heart failure | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Metabolic syndrome | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Metabolic Syndrome Criteria (AHA/NHLBI 2005) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Assists to diagnose and manage metabolic syndrome | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Metabolic syndrome | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Metabolic Syndrome Criteria (ATP III) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Diagnoses of metabolic syndrome | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Dyspnea | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |mMRC (Modified Medical Research Council) Dyspnea Scale | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Stratifies severity of dyspnea in respiratory diseases, particularly COPD | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Mortality | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Modified Early Warning Score (MEWS) for Clinical Deterioration | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Determines the degree of illness of a patient | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Chest pain | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Newsom Score for Non-traumatic Chest Pain | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Rules out need for chest x-ray in chest pain patients (non-traumatic) | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Pacer | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Pacer Need After Heart Valve Surgery | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts the need for permanent pacing after cardiac valve surgery | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + | | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Pediatric Early Warning Score (PEWS) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Identifies pediatric patients at risk for clinical deterioration | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |PERC Rule for Pulmonary Embolism | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Rules out PE if no criteria are present and pre-test probability is ≤15% | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Operation | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |PTCA Mortality Prediction | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts the risk of major in-hospital complications following percutaneous coronary interventions | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Pulmonary arterial hypertension | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |REVEAL Registry Risk Score for Pulmonary Arterial Hypertension (PAH) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts survival in patients with pulmonary arterial hypertension | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Stroke | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Risk of Paradoxical Embolism (RoPE) Score | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Identifies stroke-related PFO in patients with cryptogenic stroke | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Imaging | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Romhilt-Estes Criteria for Left Ventricular Hypertrophy | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Syncope | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |San Francisco Syncope Rule | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Defines high-risk criteria for patients with syncope | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Sgarbossa's Criteria for MI in Left Bundle Branch Block | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Criteria to diagnose acute MI in patients with prior LBBB | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Imaging | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Stress Test Outcome Risk Factors | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts outcome in a community-based population undergoing stress testing | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Stroke | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |tPA Contraindications for Ischemic Stroke | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Provides inclusion/exclusion criteria when deciding to use tPA on a patient with acute ischemic stroke | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Rules out acute coronary syndrome | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Unstable Angina and Tirofiban Benefit Prediction | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Unstable Angina Risk Stratification (Piombo) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Predicts stratify risk in unstable angina | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Unstable Angina Risk Stratification (Solomon) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Identifies patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy | ||
|- | |- | ||
|} | |} |
Revision as of 02:44, 31 January 2019
Calculator project |
---|
Introduction |
Guide |
Template |
Topics |
Validated Scores |
Alphabetic Order |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
CARDIOLOGY
Topic | Calculators | Purpose |
---|---|---|
Coronary artery disease | ACTION ICU Score for Intensive Care in NSTEMI | Predicts risk of NSTEMI complications requiring ICU care |
MACE | ADAPT Protocol for Cardiac Event Risk | Assesses chest pain patients at 2 hours for risk of cardiac event |
DVT | AMUSE score | Evaluates the need to proceed with ultrasonography among patients with suspected DVT |
Anticoagulation | ATRIA Bleeding Risk Score | Determines bleeding risk for patients on warfarin |
Arrythmia | ATRIA Stroke Risk Score | Determines stroke risk in patients with atrial fibrillation |
Arrythmia/Stroke | Atrial Fibrillation Five Year Risk of Stroke (Framingham Heart Study) | Predicts 5-year risk of stroke in patients with atrial fibrillation |
Arrythmia/Stroke | Atrial Fibrillation Five Year Risk of Stroke or Death (Framingham Heart Study) | Predicts 5-year risk of stroke or death in patients with atrial fibrillation |
Alcoholism | CAGE Questions for Alcohol Use | Screens for excessive drinking and alcoholism |
Syncope | Canadian Syncope Risk Score | Predicts 30-day serious adverse events in patients presenting with syncope |
VTE | Caprini score | Stratifies risk of VTE in surgical patients |
MACE | Cardiac Risk Index for AAA Surgery (Lee) | Calculates the approximate risk of cardiac complication after AAA surgery |
MACE | Cardiac Risk Index for Abdominal Surgery (Lee) | Calculates the approximate risk of cardiac complication after abdominal surgery |
MACE | Cardiac Risk Index for Pre-Operative Risk, revised | Estimates risk of cardiac complications after noncardiac surgery |
MACE | Cardiovascular Risk Assessment (10-year, PROCAM Score, Munster Heart Study) | Predicts 10-year cardiovascular risk based on risk factors like history of MI, diabetes or high cholesterol |
Cardiac arrest | CART (Cardiac Arrest Risk Triage) Score | Predicts risk of in-hospital cardiac arrest |
Arrythmia/Stroke | CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk | Calculates stroke risk for patients with atrial fibrillation, possibly better than the CHADS₂ Score |
Arrythmia/Stroke | CHADS₂ Score for Atrial Fibrillation Stroke Risk | Estimates stroke risk in patients with atrial fibrillation |
Survival | Charlson Comorbidity Index (CCI) | Predicts 10-year survival in patients with multiple comorbidities |
Stroke | Cincinnati Prehospital Stroke Severity Scale (CP-SSS) | Predicts large vessel occlusion (LVO) and severe stroke in patients with stroke symptoms |
Coronary artery disease/Bleeding | CRUSADE Score for Post-MI Bleeding Risk | Stratifies bleeding risk after NSTEMI |
VTE | DASH Prediction Score for Recurrent VTE | Predicts likelihood of recurrence of first VTE |
Coronary artery disease | Dual Antiplatelet Therapy (DAPT) Score | Predicts which patients will benefit from prolonged DAPT after coronary stent placement |
Syncope | EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope | Predicts likelihood that syncope is from cardiac cause |
VTE | Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis | Predicts need for VTE prophylaxis in admitted patients |
PE | Geneva score for PE, original | Determines the pre-test probability of PE based on a patient's risk factors and clinical findings |
PE | Geneva score for PE, revised | Objectifies risk of PE, like Wells’ score |
PE | Geneva score for PE, simplified | Determines the pre-test probability of PE based on a patient's risk factors and clinical findings |
Cardiac arrest/Survival | GO-FAR (Good Outcome Following Attempted Resuscitation) Score | Predicts survival to discharge with good outcome after in-hospital cardiac arrest |
Coronary artery disease | Grace Risk Score for All-Cause Mortality From Discharge to 6 Months | Assesses the risk of 6-month mortality among patients with acute coronary syndrome |
Coronary artery disease | Grace Risk Score for In-Hospital Mortality | Assesses the risk of in-hospital mortality among patients with acute coronary syndrome |
DVT | HAMILTON score | Assesses the pretest probability of DVT among ambulatory outpatients |
Bleeding | HAS-BLED Score for Major Bleeding Risk | Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care |
Coronary artery disease | HEART Pathway for Early Discharge in Acute Chest Pain | Identifies emergency department patients with acute chest pain for early discharge |
MACE | HEART Score for Major Cardiac Events | Predicts 6-week risk of major adverse cardiac event |
Arrythmia/Bleeding | HEMORR₂HAGES Score for Major Bleeding Risk | Quantifies risk of hemorrhage in elderly patients with AFib |
PE | Hestia Criteria for Outpatient Pulmonary Embolism Treatment | Identifies low-risk PE patients safe for outpatient treatment |
Bleeding | IMPROVE bleeding risk score | Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission |
VTE | IMPROVE VTE risk score | Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge |
VTE | IMPROVEDD VTE risk score | Estimates the probability of venous thromboembolism from the time of hospital admission up to 77 days |
Infective endocarditis/Mortality | Infective Endocarditis (IE) Mortality Risk Score | Predicts mortality at 6 months in patients with infective endocarditis |
Coronary artery disease | Marburg Heart Score (MHS) | Rules out coronary artery disease in primary care patients with chest pain |
Nephropathy | Mehran Score for Post-PCI Contrast Nephropathy | Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) |
Syncope/Mortality | OESIL Score for Syncope | Estimates 12-month all-cause mortality in patients presenting with syncope |
Heart failure | Ottawa Heart Failure Risk Scale (OHFRS) | Identifies ED patients with heart failure at high risk for serious adverse events |
VTE | Padua Prediction Score for Risk of VTE | Determines anticoagulation need in hospitalized patients by risk of VTE |
PE | PESI (Pulmonary Embolism Severity Index) | Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria |
PE | PESI (Pulmonary Embolism Severity Index), simplified | Predicts 30-day outcome of patients with PE, with fewer criteria than the original PESI |
PE/Bleeding | RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment | Determine the risk of major bleeding during anticoagulant therapy |
Stroke/Mortality | SOAR Score for Stroke, modified | Predicts short-term mortality in acute ischemic stroke |
Coronary artery disease | TIMI Risk Score for STEMI | Estimates mortality in patients with STEMI |
Coronary artery disease | TIMI Risk Score for UA/NSTEMI | Estimates mortality for patients with unstable angina and non-ST elevation MI |
DVT | Wells score for DVT, modified | Estimates the pre-test probability of DVT |
DVT | Wells score for DVT, original | Calculates Wells' Score for risk of DVT |
PE | Wells score for Pulmonary Embolism | Objectifies risk of pulmonary embolism |
PE | Wells score for pulmonary embolism, modified | Estimates the pre-test probability of PE |
PE | Wells score for pulmonary embolism, simplified | Estimates the pre-test probability of PE |
Anesthesia | Cardiac Anesthesia Risk Evaluation Score (CARE) | Predicts mortality and morbidity after cardiac surgery |
Duke Activity Status Index (DASI) | Estimates functional capacity | |
Ehlers-Danlos Syndrome | Ehlers-Danlos Syndrome IV (vascular type) Diagnostic Criteria | Diagnoses Ehlers-Danlos Syndrome IV (vascular type) |
Coronary artery disease | Emergency Department Assessment of Chest Pain Score (EDACS) | Identifies chest pain patients with low risk of major adverse cardiac event |
MACE | EuroSCORE for Cardiac Surgery Risk Assessment | Estimates the mortality among cardiac surgical adult patients |
MACE | Framingham 10 Year Coronary Risk Prediction by LDL (1998 paper) | Predicts 10-year risk of coronary heart disease |
MACE | Framingham 10 Year Coronary Risk Prediction by Total Cholesterol (1998 paper) | Predicts 10-year risk of coronary heart disease |
MACE | Framingham 10 Year Risk of General Cardiovascular Disease (2008 paper) | Predicts 10-year risk of heart disease |
Heart failure | Framingham Heart Failure Diagnostic Criteria | Diagnoses heart failure based on major and minor criteria |
Heart failure | GWTG-Heart Failure Risk Score | Predicts in-hospital all-cause heart failure mortality |
Takayasu arteritis | Indian Takayasu Clinical Activity Score (ITAS2010) | Differentiates between active and inactive disease in Takayasu arteritis (TA) |
Bleeding | Intracranial Bleeding Risk from Thrombolytic Therapy of MI | Estimates the risk of intracranial hemorrhage associated with thrombolytic therapy among MI patients |
Acute Rheumatic Fever | Jones Criteria for Acute Rheumatic Fever Diagnosis | Diagnoses acute rheumatic fever based on major and minor criteria |
Kawasaki Disease | Kawasaki Disease Diagnostic Criteria | Diagnoses Kawasaki Disease |
Heart failure | Killip Classification for Heart Failure | Quantifies severity of heart failure in ACS and predicts 30-day mortality |
Readmission/Mortality | LACE Index for Readmission | Predicts 30-day readmission or death in patients on medicine and surgery wards |
Heart failure/Mortality | MAGGIC Risk for Heart Failure | Estimates 1- and 3- year mortality in heart failure |
Metabolic syndrome | Metabolic Syndrome Criteria (AHA/NHLBI 2005) | Assists to diagnose and manage metabolic syndrome |
Metabolic syndrome | Metabolic Syndrome Criteria (ATP III) | Diagnoses of metabolic syndrome |
Dyspnea | mMRC (Modified Medical Research Council) Dyspnea Scale | Stratifies severity of dyspnea in respiratory diseases, particularly COPD |
Mortality | Modified Early Warning Score (MEWS) for Clinical Deterioration | Determines the degree of illness of a patient |
Chest pain | Newsom Score for Non-traumatic Chest Pain | Rules out need for chest x-ray in chest pain patients (non-traumatic) |
Pacer | Pacer Need After Heart Valve Surgery | Predicts the need for permanent pacing after cardiac valve surgery |
Pediatric Early Warning Score (PEWS) | Identifies pediatric patients at risk for clinical deterioration | |
PE | PERC Rule for Pulmonary Embolism | Rules out PE if no criteria are present and pre-test probability is ≤15% |
Operation | PTCA Mortality Prediction | Predicts the risk of major in-hospital complications following percutaneous coronary interventions |
Pulmonary arterial hypertension | REVEAL Registry Risk Score for Pulmonary Arterial Hypertension (PAH) | Predicts survival in patients with pulmonary arterial hypertension |
Stroke | Risk of Paradoxical Embolism (RoPE) Score | Identifies stroke-related PFO in patients with cryptogenic stroke |
Imaging | Romhilt-Estes Criteria for Left Ventricular Hypertrophy | Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy |
Syncope | San Francisco Syncope Rule | Defines high-risk criteria for patients with syncope |
Coronary artery disease | Sgarbossa's Criteria for MI in Left Bundle Branch Block | Criteria to diagnose acute MI in patients with prior LBBB |
Imaging | Stress Test Outcome Risk Factors | Predicts outcome in a community-based population undergoing stress testing |
Stroke | tPA Contraindications for Ischemic Stroke | Provides inclusion/exclusion criteria when deciding to use tPA on a patient with acute ischemic stroke |
Coronary artery disease | Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid | Rules out acute coronary syndrome |
Coronary artery disease | Unstable Angina and Tirofiban Benefit Prediction | Predicts adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris |
Coronary artery disease | Unstable Angina Risk Stratification (Piombo) | Predicts stratify risk in unstable angina |
Coronary artery disease | Unstable Angina Risk Stratification (Solomon) | Identifies patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy |
CRITICAL CARE
Topic | Calculators | Purpose |
---|---|---|
Stroke | Cincinnati stroke scale | |
SIRS, Sepsis, and Septic Shock Criteria | ||
qSOFA (Quick SOFA) Score for Sepsis | ||
GASTROENTEROLOGY
Topic | Calculators | Purpose |
---|---|---|
Liver disease | MELD Score | |
Liver disease | Child-Pugh score for cirrhosis mortality | |
Pancreatitis | Ranson criteria | |
Pericarditis | Tygerberg score | |
HEMATOLOGY/ONCOLOGY
Topic | Calculators | Purpose |
---|---|---|
Myelofibrosis | DIPSS Plus Score | |
CBC | Absolute Neutrophil Count (ANC) | |
INFECTIOUS DISEASE
Topic | Calculators | Purpose |
---|---|---|
ENT | Centor Score (Modified/McIsaac) for Strep Pharyngitis | |
NEPHROLOGY
Topic | Calculators | Purpose |
---|---|---|
Creatinine clearance | ||
Sodium correction for hyperglycemia | ||
Fractional Excretion of Sodium (FENa) | ||
Calcium correction for hypoalbuminemia | ||
Fluid | Maintenance fluids calculations | |
NEUROLOGY
Topic | Calculators | Purpose |
---|---|---|
Level of consciousness | Glasgow coma scale | |
Level of consciousness | Pediatric Glasgow Coma Scale | |
Stroke | Cincinnati stroke scale | |
Stroke | NIH Stroke Scale/Score (NIHSS) | |
PEDIATRICS
Topic | Calculators | Purpose |
---|---|---|
Level of consciousness | Pediatric Glasgow Coma Scale | |
Neonatology | Apgar score | |
PULMONOLOGY
Topic | Calculators | Purpose |
---|---|---|
Pneumonia | CURB-65 | |
Pneumonia | Pneumonia severity index | |
ORTHOPEDICS
Topic | Calculators | Purpose |
---|---|---|
Open Fractures | Mangled Extremity Score | Clinician completed the score to determine which mangled limbs will eventually come to amputation. |
Open Fractures | Ganga Hospital Open Injury Score (GHOIS) | Clinician completed the score to help them in decision making regarding salvage in IIIB injuries. |
Knee (Anterior Cruciate Ligament) | Modified Cincinnati Rating system | |
Knee (Anterior Cruciate Ligament) | Tegner Lysholm Knee Scoring Scale | |
Knee (Anterior Cruciate Ligament) | KOOS (Knee Injury & Osteoarthritis Outcome) | |
Knee (Osteoarthritis) | Oxford Knee Score | |
Knee (Osteoarthritis) | KOOS (Knee Injury & Osteoarthritis Outcome) | |
Knee (Osteoarthritis) | WOMAC Score | |
Knee (Osteoarthritis) | IKDC | |
Knee (Osteoarthritis) | Knee Society Score (KSS) | |
Foot/Ankle | American Foot & Ankle Score | |
Foot/Ankle | Foot & Ankle Disability Index | |
Wrist | MAYO Wrist Score | |
Wrist | DASH (Disabilities of arm, shoulder & hand) Score | |
Wrist | Quick-DASH Score | |
Hand | Michigan Hand Outcomes Questionnaire | |
Hand | DASH (Disabilities of arm, shoulder & hand) Score | |
Hand | Quick-DASH Score | |
Lumbar Spine | Oswestry Low Back Pain Score | |
Lumbar Spine | Modified Oswestry Low Back Pain Score | |
Lumbar Spine | Back Pain Index | |
Cervical Spine | Vernon & Mior Cervical Spine Score | |
Hip | Harris Hip Score | |
Hip | Oxford Hip Score | |
Hip | HOOS (Hip disability and Osteoarthritis Outcome) | |
Hip | WOMAC Score | |
Shoulder | Constant Shoulder Score | |
Shoulder | UCLA Shoulder rating scale | |
Shoulder | Oxford Shoulder Score | |
Shoulder | American Shoulder And Elbow Surgeons (ASES) Society Score | |
Shoulder | DASH (Disabilities of arm, shoulder & hand) Score | |
Shoulder | Quick-DASH Score | |
Shoulder (Instability) | Rowe Score for Instability | |
Shoulder (Instability) | Oxford Shoulder Instability Score | |
Shoulder (Instability) | WOSI (Western Ontario Shoulder Instability Index) | |
Elbow | MAYO Elbow Score | |
Elbow | Oxford Elbow Score | |
Elbow | DASH (Disabilities of arm, shoulder & hand) Score | |
Elbow | Quick-DASH Score | |
VAS | VAS Score | |
Psychological | DRAM (Distress and Risk Assessment Method) |